ATAI LIFE SCIENCES BV (ATAI) EUR0.10
Sell:$4.72Buy:$4.76
$0.11
(2.39%)
Prices delayed by at least 15 minutes
- This stock can be held in a
Create an alert
Stocks and Shares ISASell:$4.72
Buy:$4.76
Change:$0.11
(2.39%)
$0.11
(2.39%)Prices delayed by at least 15 minutes
Sell:$4.72
Buy:$4.76
Change:$0.11
(2.39%)
$0.11
(2.39%)Prices delayed by at least 15 minutes
Company Information
About this company
ATAI Life Sciences NV is a clinical-stage biopharmaceutical company. The Company focused on developing treatments for mental health disorders. The Company's pipeline includes psychedelic and non-psychedelic compounds targeting depression, anxiety, and other unmet needs in psychiatry.
Key people
Christian Angermayer
Chairman of the Supervisory Board
Srinivas Rao
Chief Executive Officer, Co-Founder, Interim Managing Director
Anne Johnson
Chief Financial Officer
Gerd G. Kochendoerfer
Chief Operating Officer
Glenn Frank Short
Chief Scientific Officer
Kevin James Craig
Chief Medical Officer
Scott N. Braunstein
Independent Supervisory Director
Laurent Fischer
Independent Supervisory Director
Sabrina Martucci Johnson
Independent Supervisory Director
Amir Kalali
Independent Supervisory Director
Andrea Heslin Smiley
Independent Supervisory Director
Click to see more
Key facts
- EPICATAI
- LocationNetherlands
- SectorHealthcare
- IndustryBiotechnology & Drugs
- ISINNL0015000DX5
- Market cap$996.67m
- Employees54
- Shares in issue214.34m
- ExchangeNASDAQ
- Index
- Website
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.